Reasons for Not Starting Antiretroviral Therapy in HIV-1-infected Individuals: A Changing Landscape

Fehr, Jan and Nicca, Dunja and Goffard, Jean-Christophe and Haerry, David and Schlag, Michael and Papastamopoulos, Vasileios and Hoepelman, Andy and Skoutelis, Athanasius and Diazaraque, Ruth and Ledergerber, Bruno. (2016) Reasons for Not Starting Antiretroviral Therapy in HIV-1-infected Individuals: A Changing Landscape. Infection, 44 (4). pp. 521-529.

Full text not available from this repository.

Official URL: https://edoc.unibas.ch/62849/

Downloads: Statistics Overview


A cross-sectional survey was conducted to better understand why chronically HIV-1-infected individuals stratified by CD4 count (≤349; 350-499; ≥500 cells/μL) were not on antiretroviral therapy (ART).; Before the consultation, treatment-naive patients and their physicians independently completed a 90-item-questionnaire about barriers and their readiness to start/defer ART. The study was carried out at 34 sites in nine countries in Europe and Australia.; Between December 2011 and October 2012, 508 pairs of patient- and physician-questionnaires were completed. 426 (84 %) patients were male and 39 (8 %), 138 (27 %), and 330 (65 %) were in the three stratified groups based on CD4 count, respectively. In the category 'Body and symptoms' the most commonly identified reason for patients not to start was: "As long as I feel good I don't have to take medication" (44 %). Less than 20 % of respondents indicated fears of side effects and toxicity or problems to manage pills. Most patients were in the lowest stage of treatment-readiness (N = 323, 68 %), especially patients with CD4 cells ≥500 cells/μL (N = 240, 79 %). Physicians answered in 92 (18 %) cases that ART was not indicated for CD4 cells <500 cells/μL. Main reasons for physicians not starting treatment for these patients were their perception that patients were 'too depressed' (13 %) or that they had not known them long enough (13 %).; Nowadays patient-barriers to ART are commonly related to health-and treatment-beliefs compared to fear of toxicity or ART manageability in the past. This new barrier pattern seems to reflect the era of well tolerated, easier ART regimens and has to be considered in light of the new recommendations to treat all HIV-infected individuals regardless of the CD4 cell count.
Faculties and Departments:03 Faculty of Medicine > Departement Public Health > Institut für Pflegewissenschaft
UniBasel Contributors:Nicca, Dunja
Item Type:Article, refereed
Article Subtype:Research Article
Note:Publication type according to Uni Basel Research Database: Journal article
Identification Number:
Last Modified:21 May 2020 13:44
Deposited On:21 May 2020 13:44

Repository Staff Only: item control page